First-line temozolomide chemotherapy in progressive low-grade astrocytomas after radiotherapy: molecular characteristics in relation to response

W. Taal, H.J. Dubbink, C.B.L. Zonnenberg, B.A. Zonnenberg, T.J. Postma, J.M.M. Gijtenbeek, W. Boogerd, F.H. Groenendijk, J.M. Kros, M.C.M. Kouwenhoven, R. van Marion, I. van Heuvel, B. van der Holt, J.E.C. Bromberg, P.A.E.S. Smitt, W.N.M. Dinjens, M.J. van den Bent

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)235-241
JournalNeuro-Oncology
Volume13
Issue number2
DOIs
Publication statusPublished - 2011

Cite this

Taal, W., Dubbink, H. J., Zonnenberg, C. B. L., Zonnenberg, B. A., Postma, T. J., Gijtenbeek, J. M. M., ... van den Bent, M. J. (2011). First-line temozolomide chemotherapy in progressive low-grade astrocytomas after radiotherapy: molecular characteristics in relation to response. Neuro-Oncology, 13(2), 235-241. https://doi.org/10.1093/neuonc/noq177